1. Home
  2. KALV vs HZO Comparison

KALV vs HZO Comparison

Compare KALV & HZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

N/A

Current Price

$15.64

Market Cap

757.7M

Sector

Health Care

ML Signal

N/A

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

N/A

Current Price

$30.00

Market Cap

626.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
KALV
HZO
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto & Home Supply Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
757.7M
626.5M
IPO Year
2014
1998

Fundamental Metrics

Financial Performance
Metric
KALV
HZO
Price
$15.64
$30.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$30.00
$30.00
AVG Volume (30 Days)
564.9K
587.3K
Earning Date
04-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
$2,309,288,000.00
Revenue This Year
N/A
$3.02
Revenue Next Year
$108.37
$4.04
P/E Ratio
N/A
N/A
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$16.85
52 Week High
$19.00
$31.60

Technical Indicators

Market Signals
Indicator
KALV
HZO
Relative Strength Index (RSI) 53.36 56.58
Support Level $14.45 $24.34
Resistance Level $16.33 $31.60
Average True Range (ATR) 0.69 1.66
MACD 0.07 -0.01
Stochastic Oscillator 80.05 60.99

Price Performance

Historical Comparison
KALV
HZO

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

Share on Social Networks: